Recent Updates
Recently added Catalysts
UHS

Steve Filton Chief Financial Officer

Key Takeaway: CONTACT: Steve Filton Chief Financial Officer October 26, 2016 610-768-3300 UNIVERSAL HEALTH SERVICES, INC. REPORTS 2016 THIRD QUARTER FINANCIAL RESULTS AND NARROWS 2016 FULL YEAR Consolidated Results of Operations, As Reported and As Adjusted Three-month periods end

Full Press Release Details

CONTACT: Steve Filton
Chief Financial Officer October 26, 2016
610-768-3300
UNIVERSAL HEALTH SERVICES, INC. REPORTS
2016 THIRD QUARTER FINANCIAL RESULTS AND NARROWS 2016 FULL YEAR
Consolidated Results of Operations, As Reported and As Adjusted Three-month periods ended September 30, 2016 and 2015:
KING OF PRUSSIA, PA Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was
$151.9 million, or $1.54 per diluted share, during the third quarter of 2016 as compared to $150.3 million, or $1.48 per diluted share, during the comparable quarter of 2015. Net revenues increased 8.2% to $2.41 billion during the third quarter
of 2016 as compared to $2.23 billion during the third quarter of 2015.
For the three-month period ended September 30, 2016, our adjusted
net income attributable to UHS per diluted share, as calculated on the attached Schedule of Non-GAAP Supplemental Consolidated Statements of Income Information ( Supplemental Schedule ), increased to $1.60 per diluted share, as compared to
$1.53 per diluted share during the third quarter of 2015. As reflected on the Supplemental Schedule, included in our reported results during the third quarters of 2016 and 2015, are net unfavorable after-tax impacts of $.06 per diluted share
and $.05 per diluted share, respectively, related to the incentive income and depreciation and amortization expense recorded in connection with the implementation of electronic health records ( EHR ) applications at our acute care
Consolidated Results of Operations, As Reported and As Adjusted Nine-month periods ended September 30, 2016 and 2015:
Reported net income attributable to UHS was $528.2 million, or $5.36 per diluted share, during the first nine months of 2016 as compared to
$506.8 million, or $5.02 per diluted share, during the comparable period of 2015. Net revenues increased 8.4% to $7.29 billion during the first nine months of 2016 as compared to $6.73 billion during the comparable period of 2015.
For the nine-month period ended September 30, 2016, our adjusted net income attributable to UHS per diluted share, as calculated on the
Supplemental Schedule, increased to $5.52 per diluted share, as compared to $5.16 per diluted share during the comparable period of 2015. As reflected on the Supplemental Schedule, included in our reported results during the nine-month periods
ended September 30, 2016 and 2015, are net unfavorable after-tax impacts of $.16 per diluted share and $.14 per diluted share, respectively, related to the incentive income and depreciation and amortization expense recorded in connection with the
implementation of EHR applications at our acute care hospitals.
Acute Care Services Three and nine-month periods ended September 30, 2016 and
During the third quarter of 2016, at our acute care hospitals owned during both periods ( same facility basis ),
adjusted admissions (adjusted for outpatient activity) increased 4.6% and adjusted
patient days increased 3.8%, as compared to the third quarter of 2015. Net revenues from our acute care services increased 9.0% during the third quarter of 2016 as compared to the third quarter
of the prior year. At these facilities, net revenue per adjusted admission increased 3.2% while net revenue per adjusted patient day increased 4.0% during the third quarter of 2016 as compared to the comparable quarter of 2015. On a same facility
basis, the operating margin generated from our acute care services was 14.7% during the third quarter of 2016 as compared to 15.3% during the third quarter of 2015. We define operating margin as net revenues less salaries, wages and benefits, other
operating expenses and supplies expense, divided by net revenues (excluding the impact of EHR and other items, if applicable, as indicated on the Supplemental Schedules).
During the first nine months of 2016, at our acute care hospitals on a same facility basis, adjusted admissions increased 5.4% and adjusted
patient days increased 3.3%, as compared to the first nine months of 2015. Net revenues from our acute care services increased 9.5% during the first nine months of 2016 as compared to the comparable period of the prior year. At these facilities, net
revenue per adjusted admission increased 2.5% while net revenue per adjusted patient day increased 4.6% during the first nine months of 2016 as compared to the comparable period of 2015. On a same facility basis, the operating margin generated from
our acute care services was 17.9% during the first nine months of 2016 as compared to 18.3% during the comparable period of 2015.
provide care to patients who meet certain financial or economic criteria without charge or at amounts substantially less than our established rates. Because we do not pursue collection of amounts determined to qualify as charity care, they are not
reported in net revenues or in accounts receivable, net. Our acute care hospitals provided charity care and uninsured discounts, based on gross charges, amounting to approximately $370 million and $322 million during the three-month periods ended
September 30, 2016 and 2015, respectively, and approximately $1.06 billion and $872 million during the nine-month periods ended September 30, 2016 and 2015, respectively. The provision for doubtful accounts at our acute care hospitals amounted to
approximately $173 million and $185 million during the three-month periods ended September 30, 2016 and 2015, respectively, and approximately $492 million and $459 million during the nine-month periods ended September 30, 2016 and 2015,
Behavioral Health Care Services Three and nine-month periods ended September 30, 2016 and 2015:
During the third quarter of 2016, at our behavioral health care facilities on a same facility basis, adjusted admissions increased 1.3% while
adjusted patient days increased 1.1% as compared to the third quarter of 2015. At these facilities, net revenue per adjusted admission increased 1.2% while net revenue per adjusted patient day increased 1.5% during the third quarter of 2016 as
compared to the comparable quarter in 2015. On a same facility basis, our behavioral health services net revenues increased 2.7% during the third quarter of 2016, as compared to the third quarter of 2015, and the operating margins were 26.0%
and 27.4% during the third quarters of 2016 and 2015, respectively.
During the first nine months of 2016, at our behavioral health care
facilities on a same facility basis, adjusted admissions increased 0.7% while adjusted patient days increased 0.9% as compared to the comparable period of 2015. At these facilities, net revenue per adjusted admission increased 1.9% while net revenue
per adjusted patient day increased 1.7% during the first nine months of 2016 as compared to the comparable period in 2015. On a same facility basis, our behavioral health services net revenues increased 2.7% during the first nine months of
2016, as compared to the comparable period of 2015, and the operating margins were 27.3% and 28.1% during the first nine months of 2016 and 2015, respectively.
2016 Full Year Earnings Guidance Range:
Based upon the operating trends and financial results experienced during the first nine months of 2016, as calculated below, we are narrowing
our estimated range of adjusted net income attributable to UHS for the year ended December 31, 2016 to $7.16 to $7.43 per diluted share from the previously provided range of $7.12 to $7.58 per diluted share. This guidance, which excludes the
expected EHR impact for the year, increases the lower end of the previously provided range by approximately 1% and decreases the upper end of the range by approximately 2%.
Estimated range of adjusted net income attributable to UHS per diluted share for the year ended December 31, 2016 Lower End Upper End
Estimated net income attributable to UHS, per diluted share $ 6.98 $ 7.25
Estimated impact of EHR implementation, per diluted share (net of tax) 0.18 0.18
Adjusted net income attributable to UHS, per diluted share $ 7.16 $ 7.43
This guidance range also excludes the impact of future items, if applicable, that are nonrecurring or
non-operational in nature including items such as, but not limited to, gains on sales of assets and businesses, costs related to extinguishment of debt, reserves for settlements, legal judgments and lawsuits, impairments of long-lived assets, impact
of share repurchases and other material amounts that may be reflected in our financial statements that relate to prior periods. It is also subject to certain conditions including those as set forth below in General Information, Forward-Looking
Statements and Risk Factors and Non-GAAP Financial Measures.
Share Repurchase Program:
In February of 2016, our Board of Directors authorized a $400 million increase to our stock repurchase program, which increased the aggregate
authorization to $800 million from the previous $400 million authorization approved during the third quarter of 2014. Pursuant to this program, we may purchase shares of our Class B Common Stock, from time to time as conditions allow, on the
open market or in negotiated private transactions.
In conjunction with this program, during the third quarter of 2016, we have repurchased
458,410 shares at an aggregate cost of $56.6 million (approximately $124 per share). During the first nine months of 2016, we have repurchased approximately 2.0 million shares at an aggregate cost of $238.1 million (approximately $117 per
share). Since inception of the program through September 30, 2016, we have repurchased approximately 3.9 million shares at an aggregate cost of approximately $462.3 million (approximately $118 per share).
Conference call information:
will hold a conference call for investors and analysts at 9:00 a.m. eastern time on October 27, 2016. The dial-in number is 1-877-648-7971.
A live broadcast of the conference call will be available on our website at www.uhsinc.com. A replay of the call will be available
following the conclusion of the live call and will be available for one full year.
General Information, Forward-Looking Statements and Risk Factors and Non-GAAP Financial Measures:
Universal Health Services, Inc. ( UHS ) is one of the nation s largest hospital companies operating through its
subsidiaries acute care hospitals, behavioral health facilities and ambulatory centers located throughout the United States, the United Kingdom, Puerto Rico and the U.S. Virgin Islands. It acts as the advisor to Universal Health Realty Income
Trust, a real estate investment trust (NYSE:UHT). For additional information on the Company, visit our web site: http://www.uhsinc.com.
This press release contains forward-looking statements based on current management expectations. Numerous factors, including those
disclosed herein, those related to healthcare industry trends and those detailed in our filings with the Securities and Exchange Commission (as set forth in Item 1A-Risk Factors and in Item 7-Forward-Looking Statements and Risk
Factors in our Form 10-K for the year ended December 31, 2015 and in Item 2-Forward Looking Statements and Risk Factors in our Form 10-Q for the quarterly period ended June 30, 2016), may cause the results to differ materially from those
anticipated in the forward-looking statements. Many of the factors that will determine our future results are beyond our capability to control or predict. These statements are subject to risks and uncertainties and therefore actual results may
differ materially. Readers should not place undue reliance on such forward-looking statements which reflect management s view only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements,
or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
operating income, operating margin, adjusted net income attributable to UHS, adjusted net income attributable to UHS per diluted share and earnings before interest, taxes, depreciation and amortization ( EBITDA ), which are non-GAAP
financial measures ( GAAP is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. In addition, we believe that, when applicable, comparing and
discussing our financial results based on these measures, as calculated, is helpful to our investors since it neutralizes the effect in each year of material items related to the implementation of EHR applications at our acute care hospitals and
other items that are nonrecurring or non-operational in nature including, but not limited to, costs related to extinguishment of debt, gains on sales of assets and businesses, reserves for settlements, legal judgments and lawsuits, impairments of
long-lived assets and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. To obtain a complete understanding of our financial performance these measures should be examined in
connection with net income, determined in accordance with GAAP, as presented in the condensed consolidated financial statements and notes thereto in this report or in our other filings with the Securities and Exchange Commission including our Report
on Form 10-K for the year ended December 31, 2015 and our Report on Form 10-Q for the quarterly period ended June 30, 2016. Since the items included or excluded from these measures are significant components in understanding and assessing financial
performance under GAAP, these measures should not be considered to be alternatives to net income as a measure of our operating performance or profitability. Since these measures, as presented, are not determined in accordance with GAAP and are thus
susceptible to varying calculations, they may not be comparable to other similarly titled measures of other companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.
Our acute care hospitals are eligible for Medicare and Medicaid EHR incentive payments upon implementation of the EHR application, once they
have demonstrated meaningful use of certified EHR technology for the applicable stage or have completed attestations to their adoption or implementation of certified EHR technology. However, there may be timing differences in the recognition of
income and expenses recorded in connection with the implementation of the EHR application which may cause material period-to-period changes in our future results of operations. Pursuant to
regulations, hospitals that did not qualify as a meaningful user of EHR by 2015 are subject to a reduced market basket update to the inpatient prospective payment system standardized amount in 2015 and each subsequent fiscal year. We believe that
all of our acute care hospitals have met the applicable meaningful use criteria and therefore are not subject to a reduced market basked update to the inpatient prospective payment standardized amount. Under the HITECH Act, hospitals must continue
to meet the applicable meaningful use criteria in each fiscal year or they will be subject to a market basket update reduction in a subsequent fiscal year.
Universal Health Services, Inc.
Consolidated Statements of Income
(in thousands, except per share amounts)
Three months Nine months
ended September 30, ended September 30,
2016 2015 2016 2015
Net revenues before provision for doubtful accounts $ 2,610,911 $ 2,439,071 $ 7,869,352 $ 7,271,852
Less: Provision for doubtful accounts 201,039 211,416 578,827 543,640
Net revenues 2,409,872 2,227,655 7,290,525 6,728,212
Operating charges:
Salaries, wages and benefits 1,149,729 1,057,226 3,428,801 3,132,993
Other operating expenses 597,270 529,383 1,744,849 1,571,060
Supplies expense 257,793 242,259 767,465 721,979
Depreciation and amortization 103,712 99,442 309,172 295,697
Lease and rental expense 23,799 24,544 73,057 70,631
Electronic health records incentive income 0 (356 ) 0 (1,751 )
2,132,303 1,952,498 6,323,344 5,790,609
Income from operations 277,569 275,157 967,181 937,603
Interest expense, net 32,129 27,130 92,171 84,851
Income before income taxes 245,440 248,027 875,010 852,752
Provision for income taxes 88,175 84,373 306,577 293,371
Net income 157,265 163,654 568,433 559,381
Less: Income attributable to noncontrolling interests 5,400 13,367 40,232 52,602
Net income attributable to UHS $ 151,865 $ 150,287 $ 528,201 $ 506,779
Basic earnings per share attributable to UHS (a) $ 1.56 $ 1.52 $ 5.43 $ 5.12
Diluted earnings per share attributable to UHS (a) $ 1.54 $ 1.48 $ 5.36 $ 5.02
Universal Health Services, Inc.
Footnotes to Consolidated Statements of Income
(in thousands, except per share amounts)
Three months Nine months
ended September 30, ended September 30,
2016 2015 2016 2015
(a) Earnings per share calculation:
Basic and diluted:
Net income attributable to UHS $ 151,865 $ 150,287 $ 528,201 $ 506,779
Less: Net income attributable to unvested restricted share grants (69 ) (82 ) (242 ) (221 )
Net income attributable to UHS - basic and diluted $ 151,796 $ 150,205 $ 527,959 $ 506,558
Weighted average number of common shares - basic 97,118 98,858 97,278 98,924
Basic earnings per share attributable to UHS: $ 1.56 $ 1.52 $ 5.43 $ 5.12
Weighted average number of common shares 97,118 98,858 97,278 98,924
Add: Other share equivalents 1,203 2,301 1,257 1,987
Weighted average number of common shares and equiv. - diluted 98,321 101,159 98,535 100,911
Diluted earnings per share attributable to UHS: $ 1.54 $ 1.48 $ 5.36 $ 5.02
Universal Health Services, Inc.
Schedule of Non-GAAP Supplemental Consolidated Statements of Income Information ( Supplemental Schedule )
For the three months ended September 30, 2016 and 2015
(in thousands, except per share amounts)
Three months ended Three months ended
September 30, 2016 September 30, 2015
Net revenues before provision for doubtful accounts $ 2,610,911 $ 2,439,071
Less: Provision for doubtful accounts 201,039 211,416
Net revenues 2,409,872 100.0 % 2,227,655 100.0 %
Operating charges:
Salaries, wages and benefits 1,149,729 47.7 % 1,057,226 47.5 %
Other operating expenses 597,270 24.8 % 529,383 23.8 %
Supplies expense 257,793 10.7 % 242,259 10.9 %
EHR incentive income 0 0.0 % (356 ) 0.0 %
2,004,792 83.2 % 1,828,512 82.1 %
Operating income/margin ( EBITDAR ) 405,080 16.8 % 399,143 17.9 %
Lease and rental expense 23,799 24,544
Income attributable to noncontrolling interests 5,400 13,367
Earnings before depreciation and amortization, interest expense, and income taxes ( EBITDA ) 375,881 15.6 % 361,232 16.2 %
Depreciation and amortization 103,712 99,442
Interest expense, net 32,129 27,130
Income before income taxes 240,040 234,660
Provision for income taxes 88,175 84,373
Net income attributable to UHS $ 151,865 $ 150,287
Last updated: Oct 26, 2016